Understanding Mullerian Anomalies and Their Treatment
Diagnostic, Therapeutic and Reproductive Aspects of Patients with Mullerian Anomalies: a Prospective Cohort
This study is trying to learn more about rare reproductive system conditions in women to see how they affect fertility and if new diagnostic tools and surgeries can help improve treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | N/A to 45 Years |
| Sex | Female |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT04627818 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the understanding of Mullerian anomalies, which are rare congenital conditions affecting the female reproductive system. It focuses on identifying the clinical implications, including reproductive issues and obstetric complications, associated with these anomalies. The study also seeks to evaluate the effectiveness of improved diagnostic tools and minimally invasive surgical treatments that may help preserve and enhance fertility in affected women. By gathering comprehensive data, the study hopes to provide insights that can lead to better management of these conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are women under 45 years old who have a uterus and a diagnosed Mullerian anomaly.
Not a fit: Patients without a uterus or those over the age of 45 may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for women with Mullerian anomalies, enhancing their reproductive health.
How similar studies have performed: While Mullerian anomalies are rare, previous studies have shown that improved diagnostic and surgical approaches can lead to better outcomes, suggesting potential success for this study's objectives.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women with a uterus * presence of a mullerian variation * Maximum age 45y Exclusion Criteria: * women without a uterus * aged \>45y
Where this trial is running
Ghent
- Ghent University hospital — Ghent, Belgium (Recruiting)
Study contacts
- Principal investigator: Tjalina Hamerlynck — University Hospital, Ghent
- Study coordinator: Eline Meireson
- Email: eline.meireson@uzgent.be
- Phone: 093327817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.